OneMedNet Corp financial data

Symbol
ONMD, ONMDW on Nasdaq
Industry
Services-Commercial Physical & Biological Research
Location
Trident Court, 1 Oakcroft Road, Chessington, Surrey, United Kingdom
State of incorporation
DE
Fiscal year end
December 31
Former names
Data Knights Acquisition Corp. (to 11/7/2023)
Latest financial report
10-Q - Q3 2024 - Dec 17, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 9.35 % +522%
Debt-to-equity -111 % -63.3%
Return On Equity 65.5 % -57.7%
Return On Assets -617 % -75.6%
Operating Margin -940 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28M shares -13.3%
Common Stock, Shares, Outstanding 28M shares +477%
Entity Public Float 9.7M USD
Common Stock, Value, Issued 2K USD +340%
Weighted Average Number of Shares Outstanding, Basic 27.9M shares +551%
Weighted Average Number of Shares Outstanding, Diluted 27.9M shares +551%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 939K USD -56.4%
Cost of Revenue 1.21M USD -22.9%
Research and Development Expense 1.63M USD -26.4%
Selling and Marketing Expense 924K USD -42.4%
General and Administrative Expense 6.01M USD +42.1%
Operating Income (Loss) -8.83M USD -5.91%
Nonoperating Income (Expense) -1.42M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -33.8M USD -10.9%
Income Tax Expense (Benefit) 18K USD
Net Income (Loss) Attributable to Parent -10.3M USD +81.7%
Earnings Per Share, Basic 2.47 USD/shares +97.8%
Earnings Per Share, Diluted 2.47 USD/shares +97.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.93M USD +216%
Accounts Receivable, after Allowance for Credit Loss, Current 63K USD -40%
Assets, Current 4.3M USD +435%
Property, Plant and Equipment, Net 84K USD -8.7%
Assets 4.39M USD +52.8%
Accrued Liabilities, Current 2.84M USD
Liabilities, Current 18.6M USD -62.7%
Other Liabilities, Noncurrent 28K USD -36.4%
Liabilities 18.7M USD -63.1%
Retained Earnings (Accumulated Deficit) -99.2M USD -11.6%
Stockholders' Equity Attributable to Parent -14.3M USD +70.1%
Liabilities and Equity 4.39M USD +52.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.55M USD -54.4%
Net Cash Provided by (Used in) Financing Activities 1.68M USD +91.8%
Net Cash Provided by (Used in) Investing Activities -6K USD +98.4%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 28.2M shares +481%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 127K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.54K USD -99.3%
Deferred Tax Assets, Valuation Allowance 7.75M USD +17.5%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 7.76M USD +17.5%
Payments to Acquire Property, Plant, and Equipment 6K USD
Property, Plant and Equipment, Gross 307K USD +16.7%
Deferred Tax Assets, Operating Loss Carryforwards 7.39M USD +12.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 85.5M USD +264%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 11K USD +83.3%
Deferred Tax Assets, Net of Valuation Allowance 6K USD +50%
Share-based Payment Arrangement, Expense 476K USD -74.1%
Interest Expense 14K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%